Literature DB >> 7635940

Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration.

S Kapadia1, J Lee, G Torre-Amione, H H Birdsall, T S Ma, D L Mann.   

Abstract

TNF alpha mRNA and protein biosynthesis were examined in the adult feline heart after stimulation with endotoxin. When freshly isolated hearts were stimulated with endotoxin in vitro, de novo TNF alpha mRNA expression occurred within 30 min, and TNF alpha protein production was detected within 60-75 min; however, TNF alpha mRNA and protein production were not detected in diluent-treated hearts. Immunohistochemical studies localized TNF alpha to endothelial cells, smooth muscle cells, and cardiac myocytes in the endotoxin-treated hearts, whereas TNF alpha immunostaining was absent in the diluent-treated hearts. To determine whether the cardiac myocyte was a source for TNF alpha production, two studies were performed. First, in situ hybridization studies, using highly specific biotinylated probes, demonstrated TNF alpha mRNA in cardiac myocytes from endotoxin-stimulated hearts; in contrast, TNF alpha mRNA was not expressed in myocytes from diluent-treated hearts. Second, TNF alpha protein production was observed when cultured cardiac myocytes were stimulated with endotoxin, whereas TNF alpha protein production was not detected in the diluent-treated cells. The functional significance of the intramyocardial production of TNF alpha was determined by examining cell motion in isolated cardiac myocytes treated with superfusates from endotoxin- and diluent-stimulated hearts. These studies showed that cell motion was depressed in myocytes treated with superfusates from the endotoxin-treated hearts, but was normal with the superfusates from the diluent-treated hearts; moreover, the negative inotropic effects of the superfusates from the endotoxin-treated hearts could be abrogated completely by pretreatment with an anti-TNF alpha antibody. Finally, endotoxin stimulation was also shown to result in the intramyocardial production of TNF alpha mRNA and protein in vivo. Thus, this study shows for the first time that the adult mammalian myocardium synthesizes biologically active TNF alpha.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7635940      PMCID: PMC286384          DOI: 10.1172/JCI118090

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  49 in total

1.  Soluble TNF binding proteins modulate the negative inotropic properties of TNF-alpha in vitro.

Authors:  S Kapadia; G Torre-Amione; T Yokoyama; D L Mann
Journal:  Am J Physiol       Date:  1995-02

2.  Plasma tumor necrosis factor levels in patients with presumed sepsis. Results in those treated with antilipid A antibody vs placebo.

Authors:  M A de Groote; M A Martin; P Densen; M A Pfaller; R P Wenzel
Journal:  JAMA       Date:  1989-07-14       Impact factor: 56.272

Review 3.  Expression of the genes of interferons and other cytokines in normal and diseased tissues of man.

Authors:  M G Tovey
Journal:  Experientia       Date:  1989-06-15

4.  The immunocytochemical localization of tumour necrosis factor and leukotriene in the rat heart and lung during endotoxin shock.

Authors:  N Tanaka; T Kita; K Kasai; T Nagano
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

5.  Improved quantification with validation of multiple mRNA species by polymerase chain reaction: application to human myocardial creatine kinase M and B.

Authors:  T S Ma; P A Brink; B Perryman; R Roberts
Journal:  Cardiovasc Res       Date:  1994-04       Impact factor: 10.787

6.  Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart.

Authors:  T Yokoyama; L Vaca; R D Rossen; W Durante; P Hazarika; D L Mann
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

7.  Inhibition of tumor necrosis factor prevents myocardial dysfunction during burn shock.

Authors:  B P Giroir; J W Horton; D J White; K L McIntyre; C Q Lin
Journal:  Am J Physiol       Date:  1994-07

8.  Rapid colorimetric detection of epidermal growth factor receptor mRNA by in situ hybridization.

Authors:  J C Iezzoni; J H Kang; C D Bucana; J A Reed; D J Brigati
Journal:  J Clin Lab Anal       Date:  1993       Impact factor: 2.352

9.  Alloantigenicity of human endothelial cells. IV. Derivation, characterization, and utilization of gonadal vein endothelia to control endothelial alloantigenicity during lymphocyte-endothelial interactions.

Authors:  E H Huang; C J Morgan; D D Sedmak; R M Ferguson; C G Orosz
Journal:  Transplantation       Date:  1994-03-15       Impact factor: 4.939

Review 10.  Immune mechanisms of cardiac disease.

Authors:  L G Lange; G F Schreiner
Journal:  N Engl J Med       Date:  1994-04-21       Impact factor: 91.245

View more
  73 in total

Review 1.  Clinical implications of tumour necrosis factor alpha antagonism in patients with congestive heart failure.

Authors:  G Torre-Amione; S S Stetson; J A Farmer
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 2.  The role of anti-cytokine therapy in the failing heart.

Authors:  A Deswal; A Misra; B Bozkurt
Journal:  Heart Fail Rev       Date:  2001-03       Impact factor: 4.214

Review 3.  The effect of cytokines on cardiac allograft function: tumor necrosis factor alpha a mediator of chronic injury.

Authors:  A Perez-Verdia; S J Stetson; S McRee; W Mazur; M M Koerner; G Torre-Amione
Journal:  Heart Fail Rev       Date:  2001-03       Impact factor: 4.214

4.  A2B adenosine receptors protect against sepsis-induced mortality by dampening excessive inflammation.

Authors:  Balázs Csóka; Zoltán H Németh; Peter Rosenberger; Holger K Eltzschig; Zoltán Spolarics; Pál Pacher; Zsolt Selmeczy; Balázs Koscsó; Leonóra Himer; E Sylvester Vizi; Michael R Blackburn; Edwin A Deitch; György Haskó
Journal:  J Immunol       Date:  2010-05-26       Impact factor: 5.422

5.  Tumor necrosis factor-α confers cardioprotection through ectopic expression of keratins K8 and K18.

Authors:  Stamatis Papathanasiou; Steffen Rickelt; Maria Eugenia Soriano; Tobias G Schips; Harald J Maier; Constantinos H Davos; Aimilia Varela; Loukas Kaklamanis; Douglas L Mann; Yassemi Capetanaki
Journal:  Nat Med       Date:  2015-08-17       Impact factor: 53.440

6.  Plasma levels of tumor necrosis factor-alpha and its receptors in patients with mitral stenosis and sinus rhythm undergoing percutaneous balloon valvuloplasty.

Authors:  Kumral Ergun Cagli; Dursun Aras; Serkan Topaloglu; Bilal Geyik; Selime Ayaz; Goksel Cagirci; Halil Lutfi Kisacik; Sule Korkmaz
Journal:  Heart Vessels       Date:  2010-03-26       Impact factor: 2.037

7.  CXCR4 modulates contractility in adult cardiac myocytes.

Authors:  Robert T Pyo; Jinliang Sui; Ashwini Dhume; Julieta Palomeque; Burns C Blaxall; George Diaz; James Tunstead; Diomedes E Logothetis; Roger J Hajjar; Alison D Schecter
Journal:  J Mol Cell Cardiol       Date:  2006-09-28       Impact factor: 5.000

8.  Pancreatic acinar cells produce, release, and respond to tumor necrosis factor-alpha. Role in regulating cell death and pancreatitis.

Authors:  A S Gukovskaya; I Gukovsky; V Zaninovic; M Song; D Sandoval; S Gukovsky; S J Pandol
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

9.  Tuning cell autophagy by diversifying carbon nanotube surface chemistry.

Authors:  Ling Wu; Yi Zhang; Chengke Zhang; Xuehui Cui; Shumei Zhai; Yin Liu; Changlong Li; Hao Zhu; Guangbo Qu; Guibin Jiang; Bing Yan
Journal:  ACS Nano       Date:  2014-02-25       Impact factor: 15.881

10.  Sanguinarine Attenuates Lipopolysaccharide-induced Inflammation and Apoptosis by Inhibiting the TLR4/NF-κB Pathway in H9c2 Cardiomyocytes.

Authors:  Yan-Yan Meng; Yuan Liu; Zhe-Fu Hu; Yao Zhang; Jian Ni; Zhen-Guo Ma; Hai-Han Liao; Qing-Qing Wu; Qi-Zhu Tang
Journal:  Curr Med Sci       Date:  2018-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.